Authors
Wolfgang A Weber, Katja Ott, Karen Becker, Hans-Joachim Dittler, Hermann Helmberger, Norbert E Avril, Gunther Meisetschlager, Raymonde Busch, Jorg-Rudiger Siewert, Markus Schwaiger, Ulrich Fink
Publication date
2001/6/15
Journal
Journal of clinical oncology
Volume
19
Issue
12
Pages
3058-3065
Publisher
American Society of Clinical Oncology
Description
PURPOSE: Preoperative chemotherapy in patients with gastroesophageal cancer is hampered by the lack of reliable predictors of tumor response. This study evaluates whether positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose (FDG) may predict response early in the course of therapy.
PATIENTS AND METHODS: Forty consecutive patients with locally advanced adenocarcinomas of the esophagogastric junction were studied by FDG-PET at baseline and 14 days after initiation of cisplatin-based polychemotherapy. Clinical response (reduction of tumor length and wall thickness by > 50%) was evaluated after 3 months of therapy using endoscopy and standard imaging techniques. Patients with potentially resectable tumors underwent surgery, and tumor regression was assessed histopathologically.
RESULTS: The reduction of tumor FDG uptake (mean ± 1 SD) after 14 days of therapy …
Total citations
20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202451731544674626861494949533841213024231916584
Scholar articles